Therapy of patients with severe asthma exacerbation
Abstract
The aim of this study was to evaluate an efficacy of short-acting β2-agonists used via a dosing inhaler and a spacer in therapy of severe asthma exacerbation (SAE).
Efficacy and safety of high-dose therapy with short-acting β2-agonists v'a a dosing inhaler and a spacer was analyzed in 15 SAE patients, the average age was 0.7±1.2 yrs. The efficacy of the treatment was evaluated with several clinical and functional parameters. Using a 3-ball scale a doctor assessed wheeze and cough intensities, accessory muscle use, pulsus paradoxus. Peak expiratory flow rate (PEF), heart beat rate (HBR), respiratory frequency (RF), and arterial blood pressure were also measured. A patient also assessed his dyspnoe with the 3-ball scale.
The therapy with short-acting β2-agonists via a dosing inhaler and a spacer is an effective and safe method for treatment of SAE patients.
About the Authors
N. A. Karoli
Саратовский государственный медицинский университет;
Областная клиническая больница
Russian Federation
Russian Federation
A. P. Rebrov
Саратовский государственный медицинский университет;
Областная клиническая больница
Russian Federation
Russian Federation
S. A. Chushinsky
Саратовский государственный медицинский университет;
Областная клиническая больница
Russian Federation
Russian Federation
References
1. Ребров А.П., Кароли И.А., Гладенина Л.А., Стешенко Р.Н. Качество диагностики астматического статуса и его лечения. Пульмонология 1999; 4: 57-62.
2. Ребров А.П., Кароли Н.А. Анализ качества лечения больных с тяжелым обострением бронхиальной астмы. В кн.: Якушин С.С. (ред.) Актуальные вопросы в клинике внутренних болезней. М.: Медицина; 2001. 265-271.
3. Чучалин А.Г., Третьяков А.В. Астматический статус. В кн.: Чучалин А.Г. (ред.) Бронхиальная астма, т.2: М.: Агар; 1997; 151-159.
4. Чучалин А.Г. Тяжелая бронхиальная астма. Рус. мед. журн. 2000; 12: 482-486.
5. Callahan C.W. Wet nebulization in acute asthma. The last refrain? Chest 2000; 117: 1226-1228.
6. Canada asthma consensus report. 1999.
7. Gates C., Rowe В.И. Holding chambers versus nebulizers for beta-agonist treatment of acute asthma. Cochrane Library 2000; Issue 3.
8. Chen Y., Dales R., Krewski D. Asthma and risk of hospitalization in Canada. Chest 2001; 119: 708-713.
9. Chou K.J., Cunningham S.J., Crain E.F. Metered-dose inhalers with spacers vs nebulizers for pediatric asthma. Arch. Pediatr. Adolesc. Med. 1995; 149: 201-205.
10. Colacone A., Afilalo М ., Wolkove N., Kreisman H. A comparison of albuterol administered by metered dose inhaler (and holding chamber) or wet nebulizer in acute asthma. Chest 1993; 104: 8354-8361.
11. FitzGerald M . Acute asthma. Brit. Med. J. 2001; 323: 841-845.
12. Ford J.G., Meyee I.FI., Sternfels P. et al. Patterns and predictors of asthma-related emergency department use in Harlem. Chest 2001; 120: 1129-1135.
13. Gibbs M .A., Camargo C.A.Jr., Rowe B.H., Silverm an R.A. Therapeutic controversies in severe acute asthma. Ac. Emerg. Med. 2000; 7: 800-815.
14. Global initiative for asthma. NHLB/WHO Workshop Report. National Heat, Lung and Blood Institute, Publication № 95-3659, 1995.
15. Hodder R.V., Callcutt L.E., Leetch J.A. Metered dose inhaler is superior to wet nebulization for emergency treatment of acute, severe asthma. Chest. 1988; 94 (suppl): 52S.
16. Idris A.H., McDermott M .F., Raucci J.C. et al. Emergency department treatment of severe asthma. Metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer. Ibid. 1993; 103: 665-672.
17. Inwald D., Roland М., Kuitert I. et al. Oxygen treatment for acute severe asthma. Brit. Med. J. 2001; 323: 98-100.
18. Karpel J.P., Aldrich Т.К., Prezant D.J. et al. Emergency treatment of acute asthma with albuterol metered-dose inhaler plus holding chamber: how often should treatments be administered? Chest 1997; 112: 348-356.
19. Kerem E., Levinson H., Schuh S. et al. Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J. Pediatr. 1993; 123: 313-317.
20. Lin Y.Z., Hsieh К.И. Metered dose inhaler and nebuliser in acute asthma. Arch. Dis. Childh. 1995; 72: 214-218.
21. Mandelberg A., Chen E., Noviski N., Priel I.E. Nebulized wet aerosol treatment in emergency department — is it essential? Comparison with large spacer device for metered-dose inhaler. Chest 1997; 112: 1501-1505.
22. National asthma education and prevention program. Expert panel report II: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institute of Health: 1997.
23. National Heat, Lung and Blood Institute Data fact sheet. Asthma statistics. 1999.
24. Raim ondi A., Schottlender J., Lombardi D., Molfino N.A. Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaled with spacer, or dry powder. Chest. 1997; 112: 24-28.
25. Rodrigo C., Rodrigo G. Salbutamol treatment of acute severe asthma in the ED: MDI versus hand-held nebulizer. Am. J. Emerg. Med. 1998; 16: 637-642.
26. Soler М ., Imhof E., Perruchoud A.P. Severe acute asthma. Pathophysiology, clinical assesessment, and treatment. Respiration 1990; 57: 114-121.
27. Turner M.O., Noertjojo K., Vedal S. et al. Risk factors for nearfatal asthma. Am. J. Respir. Crit. Care Med. 1998; 157; 1804-1809.
28. Weiss K.B., Gergen P.J., Hodgson T.A. An economic evolution of asthma in the United States. N. Engl. J. Med. 1992; 326: 862-866.
Review
For citations:
Karoli N.A., Rebrov A.P., Chushinsky S.A. Therapy of patients with severe asthma exacerbation. PULMONOLOGIYA. 2003;(5):63-70. (In Russ.)
Views:
218
Email this article 